SARTORIUS STEDIM BIOTECH (56S1.DE) Forecast, Price Target & Analyst Ratings

FRA:56S1 • FR0013154002

Current stock price

166 EUR
+5.15 (+3.2%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SARTORIUS STEDIM BIOTECH (56S1.DE).

Forecast Snapshot

Consensus Price Target

Price Target
€247.39
+ 49.03% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 23, 2026
Period
Q1 / 2026
EPS Estimate
€1.25
Revenue Estimate
765.69M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
78.95%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€247.39
Upside
+ 49.03%
From current price of €166.00 to mean target of €247.39, Based on 19 analyst forecasts
Low
€217.20
Median
€250.69
High
€275.27

Price Target Revisions

1 Month
0.00%
3 Months
2.79%

Price Target Summary

19 Wall Street analysts provided a forecast for the next 12 months for 56S1.DE. The average price target is 247.39 EUR. This implies a price increase of 49.03% is expected in the next year compared to the current price of 166.
The average price target has been revised upward by 2.79% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

56S1 Current Analyst Rating56S1 Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

56S1 Historical Analyst Ratings56S1 Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
78.95%
56S1.DE was analyzed by 19 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about 56S1.DE.
In the previous month the buy percentage consensus was at a similar level.
56S1.DE was analyzed by 19 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 23, 2026
Period
Q1 / 2026
EPS Estimate
€1.25
Revenue Estimate
765.69M
Revenue Q2Q
2.83%
EPS Q2Q
7.48%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
0.04%
Revenue (3 Months)
N/A
EPS (1 Month)
-1.90%
EPS (3 Months)
N/A

Next Earnings Summary

56S1.DE is expected to report earnings on 4/23/2026. The consensus EPS estimate for the next earnings is 1.25 EUR and the consensus revenue estimate is 765.69M EUR.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
56S1.DE revenue by date.56S1.DE revenue by date.
2.776B
-20.53%		2.78B
0.16%		2.968B
6.74%		3.221B
8.54%		3.563B
10.62%		3.932B
10.36%		4.523B
15.03%		5.111B
13.00%		5.887B
15.18%		6.535B
11.01%		7.253B
10.99%
EBITDA
YoY % growth
56S1.DE ebitda by date.56S1.DE ebitda by date.
707.9M
-44.01%		699.4M
-1.20%		857.6M
22.62%		1.013B
18.12%		1.162B
14.71%		1.317B
13.34%		1.578B
19.82%		1.823B
15.53%		2.145B
17.66%		2.38B
10.96%		2.641B
10.97%
EBIT
YoY % growth
56S1.DE ebit by date.56S1.DE ebit by date.
470.3M
-56.56%		397.7M
-15.44%		539.5M
35.66%		732.98M
35.86%		862.18M
17.63%		1.006B
16.68%		1.237B
22.96%		1.434B
15.93%		1.534B
6.97%		1.703B
11.02%		1.89B
10.98%
Operating Margin
56S1.DE operating margin by date.56S1.DE operating margin by date.
16.94%14.31%18.18%22.76%24.20%25.58%27.35%28.06%26.06%26.06%26.06%
EPS
YoY % growth
56S1.DE eps by date.56S1.DE eps by date.
4.19
-51.50%		3.50
-16.47%		4.40
25.71%		5.26
19.60%		6.33
20.35%		7.42
17.21%		9.25
24.66%		10.52
13.67%		11.61
10.32%		12.88
10.98%		14.29
10.93%

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		1.25
7.48%		1.36
15.12%		1.20
27.46%		1.43
27.29%
Revenue
Q2Q % growth		765.69M
2.83%		802.66M
7.74%		776.53M
10.04%		854.25M
10.63%
EBITDA
Q2Q % growth		239.6M
9.56%		254.94M
-10.30%		245.04M
-33.59%		275.21M
-37.28%
EBIT
Q2Q % growth		188.9M
33.69%		202.72M
57.27%		186.24M
38.16%		219.51M
81.86%

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

56S1.DE Yearly Revenue VS Estimates56S1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
56S1.DE Yearly EPS VS Estimates56S1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
19.05%
EPS Next 5 Year
19.04%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
9.46%
Revenue Next 5 Year
11.26%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
26.51%
EBIT Next 5 Year
22.89%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SARTORIUS STEDIM BIOTECH / 56S1.DE Forecast FAQ

What is the average price target for SARTORIUS STEDIM BIOTECH (56S1.DE) stock?

19 analysts have analysed 56S1.DE and the average price target is 247.39 EUR. This implies a price increase of 49.03% is expected in the next year compared to the current price of 166.

Can you provide the upcoming earnings date for SARTORIUS STEDIM BIOTECH?

SARTORIUS STEDIM BIOTECH (56S1.DE) will report earnings on 2026-04-23.

What are the consensus estimates for SARTORIUS STEDIM BIOTECH (56S1.DE) next earnings?

The consensus EPS estimate for the next earnings of SARTORIUS STEDIM BIOTECH (56S1.DE) is 1.25 EUR and the consensus revenue estimate is 765.69M EUR.

What is the number of analysts for 56S1 stock?

The number of analysts covering SARTORIUS STEDIM BIOTECH (56S1.DE) is 19.